Fred Hutch Cancer Center is a clinical research site located in Seattle, Washington, United States 98109.
Crixeo Clinical Trials Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Fred Hutch Cancer Center has participated in 11 clinical trials with 10 currently active.
Therapeutic areas: Multiple Myeloma, Colon Cancer, Metastatic Colon Cancer.
Sponsors: Karyopharm Therapeutics Inc, Sapience Therapeutics, A2 Biotherapeutics Inc..
Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Fred Hutch Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Fred Hutch Cancer Center has 11 clinical trials on record, with 10 currently active. Their work covers Multiple Myeloma, Colon Cancer, Metastatic Colon Cancer.
Fred Hutch Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.